Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

653 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nucleolin Targeting by N6L Inhibits Wnt/β-Catenin Pathway Activation in Pancreatic Ductal Adenocarcinoma.
Raineri F, Bourgoin-Voillard S, Cossutta M, Habert D, Ponzo M, Houppe C, Vallée B, Boniotto M, Chalabi-Dchar M, Bouvet P, Couvelard A, Cros J, Debesset A, Cohen JL, Courty J, Cascone I. Raineri F, et al. Among authors: cohen jl. Cancers (Basel). 2021 Jun 15;13(12):2986. doi: 10.3390/cancers13122986. Cancers (Basel). 2021. PMID: 34203710 Free PMC article.
Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression.
Ponzo M, Debesset A, Cossutta M, Chalabi-Dchar M, Houppe C, Pilon C, Nicolas-Boluda A, Meunier S, Raineri F, Thiolat A, Nicolle R, Maione F, Brundu S, Cojocaru CF, Bouvet P, Bousquet C, Gazeau F, Tournigand C, Courty J, Giraudo E, Cohen JL, Cascone I. Ponzo M, et al. Among authors: cohen jl. Cancers (Basel). 2022 Aug 31;14(17):4265. doi: 10.3390/cancers14174265. Cancers (Basel). 2022. PMID: 36077801 Free PMC article.
Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265.
Ponzo M, Debesset A, Cossutta M, Chalabi-Dchar M, Houppe C, Pilon C, Nicolas-Boluda A, Meunier S, Raineri F, Thiolat A, Nicolle R, Maione F, Brundu S, Cojocaru CF, Bouvet P, Bousquet C, Gazeau F, Tournigand C, Courty J, Giraudo E, Cohen JL, Cascone I. Ponzo M, et al. Among authors: cohen jl. Cancers (Basel). 2022 Dec 14;14(24):6160. doi: 10.3390/cancers14246160. Cancers (Basel). 2022. PMID: 36551754 Free PMC article.
Radiation therapy for triple-negative breast cancer: emerging role of microRNAs as biomarkers and radiosensitivity modifiers. A systematic review.
To NH, Nguyen HQ, Thiolat A, Liu B, Cohen J, Radosevic-Robin N, Belkacemi Y; TransAtlantic Radiation Oncology Network (TRONE) & Association of Radiotherapy, and Oncology of the Mediterranean Area (AROME). To NH, et al. Breast Cancer Res Treat. 2022 Jun;193(2):265-279. doi: 10.1007/s10549-022-06533-3. Epub 2022 Apr 9. Breast Cancer Res Treat. 2022. PMID: 35397079 Review.
Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology.
Salomon BL, Leclerc M, Tosello J, Ronin E, Piaggio E, Cohen JL. Salomon BL, et al. Among authors: cohen jl. Front Immunol. 2018 Mar 12;9:444. doi: 10.3389/fimmu.2018.00444. eCollection 2018. Front Immunol. 2018. PMID: 29593717 Free PMC article. Review.
TNFR2 blockade of regulatory T cells unleashes an antitumor immune response after hematopoietic stem-cell transplantation.
Moatti A, Debesset A, Pilon C, Beldi-Ferchiou A, Leclerc M, Redjoul R, Charlotte F, To NH, Bak A, Belkacemi Y, Salomon BL, Issa F, Michonneau D, Maury S, Cohen JL, Thiolat A. Moatti A, et al. Among authors: cohen jl. J Immunother Cancer. 2022 Apr;10(4):e003508. doi: 10.1136/jitc-2021-003508. J Immunother Cancer. 2022. PMID: 35387779 Free PMC article.
653 results